Abstract

Resistance to the extended-spectrum cephalosporin ceftriaxone in the pathogenic bacteria Neisseria gonorrhoeae is conferred by mutations in penicillin-binding protein 2 (PBP2), the lethal target of the antibiotic, but how these mutations exert their effect at the molecular level is unclear. Using solution NMR, X-ray crystallography, and isothermal titration calorimetry, we report that WT PBP2 exchanges dynamically between a low-affinity state with an extended β3–β4 loop conformation and a high-affinity state with an inward β3–β4 loop conformation. Histidine-514, which is located at the boundary of the β4 strand, plays an important role during the exchange between these two conformational states. We also find that mutations present in PBP2 from H041, a ceftriaxone-resistant strain of N. gonorrhoeae, increase resistance to ceftriaxone by destabilizing the inward β3–β4 loop conformation or stabilizing the extended β3–β4 loop conformation to favor the low-affinity drug-binding state. These observations reveal a unique mechanism for ceftriaxone resistance, whereby mutations in PBP2 lower the proportion of target molecules in the high-affinity drug-binding state and thus reduce inhibition at lower drug concentrations.

Highlights

  • Neisseria gonorrhoeae is the causative agent of the sexually transmitted infection gonorrhea, with nearly 80 million cases worldwide each year [1]

  • Since Arg502 is positioned at the junction of the β3 strand and the β3–β4 loop, we focused on tPBP2–R502CBFTA to probe for conformational changes in the β3–β4 loop region

  • Mutations of particular interest among these are F504L and N512Y in the β3–β4 loop, which we have proposed hinder the dynamics of the β3–β4 loop based on crystal structures of the ceftriaxone-acylated tPBP2H041 [18], and the G545S mutation in the loop immediately preceding α11 that we believe restricts rotation of β3 and hinders formation of the oxyanion hole

Read more

Summary

RESEARCH ARTICLE

Nicholas2,* , Christopher Davies3,* , and Pei Zhou1,* From the 1Department of Biochemistry, Duke University School of Medicine, Durham, North Carolina, USA; 2Departments of Pharmacology and Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; 3Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina, USA

Edited by Wolfgang Peti
Results
Discussion
Experimental procedures
Solution NMR measurements
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call